This week’s newsletter covers the cannabis industry’s fixation on THC potency, the therapeutic value of whole-plant cannabis products, new research on cannabinoids and diabetes and brain tumors, and emerging findings on psychedelics and long-term well-being.
Noteworthy Read
Why Can’t the Marijuana Industry Shake Its THC Addiction? (MJBizDaily)
Despite growing consumer interest in terpenes, minor cannabinoids, and full-spectrum effects, much of the legal cannabis market remains fixated on THC potency as the primary marker of quality. This emphasis pressures cultivators, retailers, and labs to chase high THC numbers—sometimes at the expense of transparency, accuracy, and product diversity.
More Noteworthy Reading
CBD and Its Entourage (Excerpted from “The Essential Guide to CBD” by the Editors of Reader’s Digest and Project CBD)
This piece from 2021 introduces the concept of the “entourage effect,” i.e. how cannabinoids and terpenes work together to enhance therapeutic effects. While research into the interplay of the compounds in cannabis is ongoing, educating consumers about the value of “whole plant” products and the fact that compounds beyond THC can play a vital role in one’s experience could be a way for the industry to mitigate the current market’s potency obsession.
Research Round-Up
Therapeutic Potential of Cannabis Plant in Diabetes (Trends in Pharmacy)
A recent review highlights how the cannabis plant may help manage diabetes through its anti-inflammatory, antioxidant, and insulin-sensitizing effects. The authors explore phytocannabinoids’ mechanisms in regulating blood glucose and preventing complications.
Read more
View more in Endocannabinoid System
Recent Advances in Therapeutic Potential of Cannabinoids Against Gliomas (PubMed)
New research underscores the promise of cannabinoids as anticancer agents for gliomas, a type of aggressive brain tumor. Studies reveal their potential to inhibit tumor growth, induce cell death, and enhance the effectiveness of conventional therapies.
Read more
View more in Endocannabinoid System
Psychedelic Experiences May Offer a Lasting Boost in Perceived Life Meaning (PsyPost)
Participants who reported meaningful psychedelic experiences were more likely to describe enhanced purpose, connection, and psychological well-being months or even years later. These long-term effects may contribute to the therapeutic appeal of psychedelics in treating existential distress and mental health conditions.
Read more
View more in Psychedelics
A heartfelt thank you to all the CBD brands whose generous support fuels Project CBD’s mission to bring you the latest in plant medicine research and journalism. We couldn’t do this work without you.
